Sensational artemisinin-piperaquine for treatment of COVID-19 ... - 04 November 2021 12:02

GUANGZHOU, China, Nov. 3, 2021 /Xinhua-AsiaNet/-- Artequick artemisinin and piperaquine tablets have once again become buzzwords across the globe, as most recently, their effectiveness in treating COVID-19 was hotly debated by live streamers on overseas social media and we media platforms. These ...

  Novavax Files COVID-19 Vaccine for Provisional Approval in New... - 04 November 2021 01:37

GAITHERSBURG, Md., Nov. 4, 2021 /PRNewswire-AsiaNet/ -- - Submission to New Zealand's Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities in New Zealand - All modules required for regulatory review of Novavax vaccine, including CMC data, are n...

  Gold Technology for Immune Response Cancer Therapy Licensed to... - 04 November 2021 01:00

AUSTIN, Texas, Nov. 3, 2021 /Medianet International-AsiaNet/ -- OncoTEX Inc. (OncoTEX), a US oncology company and member of The iQ Group Global portfolio, is pleased to announce it has acquired a gold compound platform technology that induces the body’s immune system to destroy cancer cells. The technology ...

  Nautilus and Abcam Announce Strategic Partnership to Accelerat... - 02 November 2021 23:00

SEATTLE and CAMBRIDGE, England, Nov. 2, 2021 /PRNewswire-AsiaNet/ -- As an element of Nautilus' overall reagent development and sourcing strategy, the partnership aims to accelerate research and development, and provide customers with access to Abcam's antibody development technology and expertise Nautilus Biot...

  Winner Medical to Showcase Innovations in Wound Care and Infec... - 02 November 2021 19:04

SHENZHEN, China, Nov. 2, 2021 /PRNewswire-AsiaNet/ -- Winner Medical (300888.SZ), a leading manufacturer for disposable wound care and surgical products, is set to showcase its full set of advanced solutions for wound care and O.R. infection prevention at MEDICA 2021 which is slated to run from Novem...

  Diabetes is "a pandemic of unprecedented magnitude" now affect... - 02 November 2021 19:00

BRUSSELS, Nov. 2, 2021 /PRNewswire-AsiaNet/ -- New figures from the International Diabetes Federation reveal that 537 million adults around the globe are living with diabetes The International Diabetes Federation (IDF) has released new figures showing that 537 million adults are now living ...

  Phebra Acquires Equity Stake In UK Specialty Hospital Pharma C... - 02 November 2021 15:06

SYDNEY, Nov. 2, 2021 /Medianet-International-AsiaNet/-- - Phebra takes part ownership of Flexipharm Austrading through share purchase - Builds on Phebra's Existing UK Distribution Agreement - Strengthens Phebra’s Presence in UK and Europe Sydney, Australia and Bourne End, UK, 02 November, 2021: ...

  Novavax and Serum Institute of India Receive Emergency Use Aut... - 01 November 2021 22:39

GAITHERSBURG, Md. and PUNE, India, Nov. 1, 2021 /PRNewswire-AsiaNet/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by v...

  Invetech Named Victorian Top Exporter of the Year - 30 October 2021 09:08

MELBOURNE, Australia, Oct. 30, 2021 /PRNewswire-AsiaNet/-- Invetech, an end-to-end commercialisation partner to world's foremost therapeutic and diagnostic companies, has been named the Victorian Exporter of the Year at the 2021 Governor of Victoria Export Awards (GOVEA) ( https://global.vic.gov.au/for-ex...

  Novavax Files for Provisional Approval of its COVID-19 Vaccine... - 29 October 2021 22:31

GAITHERSBURG, Md., Oct. 29, 2021 /PRNewswire-AsiaNet/ -- -- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval in Australia -- In addition to today's submission to the Therapeutic Goods Administration, the company recently filed for...